Racial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia.

ABSTRACT:

Background

Racial/ethnic minorities are at higher risk for severe COVID-19. This may be related to social determinants that lead to chronic inflammatory states. The aims of the study were to determine if there are racial/ethnic disparities with inflammatory markers and association of methylprednisolone to in hospital survival.

Methods

This was a secondary analysis of a retrospective cohort study of patients ≥ 18 years of age and admitted for severe COVID-19 pneumonia between March and June 2020 in 13 Hospitals in New Jersey, United States. Patients who received other formulation of corticosteroids were not included. Area under the receiver operating characteristics curves were performed to test for discriminatory ability of each inflammatory makers. Univariate and multivaria

SUBMITTER: Go RC 

PROVIDER: S-EPMC8919360 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature